Preclinical vitro and vivo drug discovery services
Caliper Discovery Alliances & Services (CDAS) was formed through the acquisition of NovaScreen Biosciences, a recognized leader in the performance of preclinical contract research. Since the acquisition, CDAS has greatly expanded its offering and has assembled a wide range of drug discovery and development outsourcing solutions that enable pharmaceutical and biotechnology companies to reduce costs while accelerating the pace and clinical relevance of drug discovery research. Our contract research offering is available for ‘Fee for Service’ as well as for highly customized ‘Discovery’ and ‘Alliances’ programs.
Keywords: Drug safety, oncology, immunology, animal models, efficacy, cancer, biomarkers, personalized medicine, translational medicine,
Contact Caliper Discovery Alliances $& Services:
